Chantal Bernard-Marty

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

David Gancberg, Angelo Di Leo, Fátima Cardoso et al. · Annals of Oncology · 2002 · 309 citations · Full text

Breast Oncology, Medicine, Pathology +8

Microtubule-Associated Parameters as Predictive Markers of Docetaxel Activity in Advanced Breast Cancer Patients: Results of a Pilot Study

Chantal Bernard-Marty, Isabelle Treilleux, Charles Dumontet et al. · Clinical Breast Cancer · 2002 · 76 citations

Docetaxel Activity, Breast Oncology, Oncology +9

Class III β-Tubulin Isotype Predicts Response in Advanced Breast Cancer Patients Randomly Treated Either with Single-Agent Doxorubicin or Docetaxel

Carlos M. Galmarini, Isabelle Treilleux, Fátima Cardoso et al. · Clinical Cancer Research · 2008 · 61 citations · Full text

Second malignancies following adjuvant chemotherapy:6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment ofnode-positive breast cancer patients

Chantal Bernard-Marty, Max S. Mano, Marianne Paesmans et al. · Annals of Oncology · 2003 · 46 citations · Full text

Breast Oncology, Belgian Randomized Study, Medicine +7

Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study

Florence Dalenc, Virginie Ribet, Ana B. Rossi et al. · European Journal of Cancer Care · 2017 · 35 citations